Intradermal Tests With Drugs: An Approach to Standardization

Area of Science:

• Allergy and Immunology
• Pharmacology
• Clinical Research Methodology

Background:

• Intradermal tests (IDTs) for drug allergy exhibit significant variability in performance and interpretation across different centers.
• This lack of standardization hinders the reliable comparison of IDT results.
• Variability in drug allergy testing impacts patient diagnosis and management.

Purpose of the Study:

• To introduce and evaluate a standardized method for intradermal tests (IDTs) in drug allergy.
• The goal was to reduce method-related and intercenter variability in IDT performance.
• To enhance the reliability and comparability of drug allergy testing results.

Main Methods:

• A standardized intradermal test (IDT) method using a precise 0.02 ml volume was implemented across 11 European centers.
• Local methods and the standardized European Network in Drug Allergy (ENDA) method were compared using saline and amoxicillin.
• The diameter of the initial injection wheal (Wi) was measured and analyzed for reproducibility.

Main Results:

• The most reproducible method involved expelling excess fluid from a syringe to achieve exactly 0.02 ml.
• The standardized method yielded a median Wi diameter of 5 mm for both saline and amoxicillin.
• Injection site did not influence Wi diameter, and training improved test precision.

Conclusions:

• A standardized intradermal test (IDT) method effectively reduces variability in drug allergy testing.
• This standardization enables more reliable comparisons of results between individuals and across different clinical centers.
• The findings support the adoption of standardized IDTs for improved drug allergy diagnosis.